AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Sep 22, 2022
35599_dirs_2022-09-22_c5c05150-379d-4667-9d5d-e0b2be5cadae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-09-21
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-21 | Common shares | A | 37500 | — | Acquired | 190773 | Direct |
| 2022-09-21 | Common shares | D | 19052 | $8.54 | Disposed | 171721 | Direct |
Footnotes
F1: On September 21, 2022, 37,500 restricted share units were released from their restriction.
F2: On September 21, 2022, 19,052 shares were netted back to the company to pay the taxes on the common shares released from restriction.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20